As an important effector cytokine for cancer immunity, IFNγ also has prognostic and predictive significance in basal-like or triple-negative breast cancer, arguing for a protective effect of IFNγ-mediated immune responses by vaccination. The gene discussed is IFNG; the disease is triple-negative breast carcinoma.